Frequency Therapeutics, Inc.

NasdaqCM:FREQ 株式レポート

時価総額:US$547.3m

Frequency Therapeutics マネジメント

マネジメント 基準チェック /24

We currently do not have sufficient information about the CEO.

主要情報

David Lucchino

最高経営責任者

US$3.2m

報酬総額

CEO給与比率19.9%
CEO在任期間9yrs
CEOの所有権1.7%
経営陣の平均在職期間データなし
取締役会の平均在任期間7.2yrs

経営陣の近況

Recent updates

Is Frequency Therapeutics (NASDAQ:FREQ) Weighed On By Its Debt Load?

Jan 01
Is Frequency Therapeutics (NASDAQ:FREQ) Weighed On By Its Debt Load?

Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?

Jan 19
Frequency Therapeutics (NASDAQ:FREQ) Has Debt But No Earnings; Should You Worry?

Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are Reducing Their Forecasts For This Year

Aug 18
Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are Reducing Their Forecasts For This Year

Health Check: How Prudently Does Frequency Therapeutics (NASDAQ:FREQ) Use Debt?

Jul 31
Health Check: How Prudently Does Frequency Therapeutics (NASDAQ:FREQ) Use Debt?

Frequency Therapeutics (FREQ) Investor Presentation - Slideshow

Jun 18

Frequency Therapeutics: A Look At What's Next After A Disappointing Data Readout

Apr 21

Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are More Bearish Than They Used To Be

Apr 04
Frequency Therapeutics, Inc. (NASDAQ:FREQ) Analysts Are More Bearish Than They Used To Be

We're Not Worried About Frequency Therapeutics' (NASDAQ:FREQ) Cash Burn

Mar 15
We're Not Worried About Frequency Therapeutics' (NASDAQ:FREQ) Cash Burn

If You Had Bought Frequency Therapeutics (NASDAQ:FREQ) Shares A Year Ago You'd Have Earned 55% Returns

Jan 22
If You Had Bought Frequency Therapeutics (NASDAQ:FREQ) Shares A Year Ago You'd Have Earned 55% Returns

Have Insiders Sold Frequency Therapeutics, Inc. (NASDAQ:FREQ) Shares Recently?

Dec 27
Have Insiders Sold Frequency Therapeutics, Inc. (NASDAQ:FREQ) Shares Recently?

Frequency Therapeutics to host investor event in early January next year

Dec 18

How Much Are Frequency Therapeutics, Inc. (NASDAQ:FREQ) Insiders Taking Off The Table?

Dec 10
How Much Are Frequency Therapeutics, Inc. (NASDAQ:FREQ) Insiders Taking Off The Table?

Frequency Therapeutics, Inc. (NASDAQ:FREQ) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Nov 19
Frequency Therapeutics, Inc. (NASDAQ:FREQ) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Frequency Therapeutics EPS beats by $0.16, beats on revenue

Nov 16

Frequency Therapeutics Is An Interesting Speculative Play Ahead Of Phase 2 Results

Nov 09

CEO報酬分析

Frequency Therapeutics の収益と比較して、David Lucchino の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2023n/an/a

-US$59m

Jun 30 2023n/an/a

-US$67m

Mar 31 2023n/an/a

-US$78m

Dec 31 2022US$3mUS$630k

-US$82m

Sep 30 2022n/an/a

-US$86m

Jun 30 2022n/an/a

-US$91m

Mar 31 2022n/an/a

-US$88m

Dec 31 2021US$6mUS$600k

-US$85m

Sep 30 2021n/an/a

-US$73m

Jun 30 2021n/an/a

-US$54m

Mar 31 2021n/an/a

-US$42m

Dec 31 2020US$5mUS$551k

-US$27m

Sep 30 2020n/an/a

-US$22m

Jun 30 2020n/an/a

-US$18m

Mar 31 2020n/an/a

-US$19m

Dec 31 2019US$7mUS$442k

-US$20m

Sep 30 2019n/an/a

-US$20m

Jun 30 2019n/an/a

-US$23m

Mar 31 2019n/an/a

-US$21m

Dec 31 2018US$744kUS$367k

-US$19m

報酬と市場: David's total compensation ($USD3.16M) is above average for companies of similar size in the US market ($USD2.23M).

報酬と収益: David's compensation has been consistent with company performance over the past year.


CEO(最高経営責任者

David Lucchino (53 yo)

9yrs

在職期間

US$3,159,278

報酬

Mr. David L. Lucchino is a Co-Founder of Frequency Therapeutics, Inc. and has been its Chief Executive Officer and President since November 2014. Mr. Lucchino served as Treasurer and Secretary of Frequency...


取締役

名称ポジション在職期間報酬所有権
David Lucchino
Co-Founder9yrsUS$3.16m1.73%
$ 9.5m
John LaMattina
Senior Advisor & Member of PCA Regenerative Medicine Advisory Board6.7yrsデータなしデータなし
Timothy Barberich
Independent Vice Chairman7.2yrsUS$104.32k0.22%
$ 1.2m
Robert Langer
Independent Director & Member of PCA Regenerative Medicine Advisory Board7.2yrsUS$133.32k0.66%
$ 3.6m
Cynthia Feldmann
Independent Director3.2yrsUS$92.82k0%
$ 0
Kenneth Anderson
Member of PCA Regenerative Medicine Advisory Boardno dataデータなしデータなし
Ralph Mazitschek
Member of PCA Regenerative Medicine Advisory Boardno dataデータなしデータなし
Jeffrey Karp
Member of PCA Regenerative Medicine Advisory Boardno dataデータなしデータなし
Stephen Haggarty
Member of PCA Regenerative Medicine Advisory Boardno dataデータなしデータなし
Xiaolei Yin
Member of PCA Regenerative Medicine Advisory Boardno dataデータなしデータなし
Daniel Lee
Member of Clinical Advisory Boardno dataデータなしデータなし
Joni Doherty
Member of Clinical Advisory Boardno dataデータなしデータなし

7.2yrs

平均在職期間

72.5yo

平均年齢

経験豊富なボード: FREQ's board of directors are considered experienced (7.2 years average tenure).